Structural Differences between Repressed and Derepressed Forms of p60^c-src

LITERATURE CITED

• Basu, M., R. Biswas, and M. Das. 1984. 42,000-Molecular weight EGF receptor has protein kinase activity. Nature (London) 311:477–480.
   PubMedGoogle Scholar
• Beemon, K., and T. Hunter. 1978. Characterization of Rous sarcoma virus src gene products synthesized in vitro. J. Virol. 28:551–566.
   PubMed Web of Science ®Google Scholar
• Bolen, J. B., C. J. Thiele, M. A. Israel, W. Yonemoto, L. A. Lipsich, and J. S. Brugge. 1984. Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation. Cell 38:767–777.
   PubMed Web of Science ®Google Scholar
• Brugge, J. S., and D. Darrow. 1984. Analysis of the catalytic domain of phosphotransferase activity of two avian sarcoma virus-transforming proteins. J. Biol. Chem. 259:4550–4557.
   PubMedGoogle Scholar
• Bryant, D., and J. T. Parsons. 1982. Site-directed mutagenesis of the src gene of Rous sarcoma virus: construction and characterization of a deletion mutant temperature sensitive for transformation. J. Virol. 45:1211–1216.
   Google Scholar
• Bryant, D. L., and J. T. Parsons. 1984. Amino acid alterations within a highly conserved region of the Rous sarcoma virus src gene product pp60src inactivate tyrosine protein kinase activity. Mol. Cell. Biol. 4:862–866.
   PubMedGoogle Scholar
• Cartwright, C. A., W. Eckhart, S. Simon, and P. L. Kaplan. 1987. Cell transformation by pp60c-src mutated in the carboxyterminal regulatory domain. Cell 49:83–91.
   PubMed Web of Science ®Google Scholar
• Cartwright, C. A., P. L. Kaplan, J. A. Cooper, T. Hunter, and W. Eckhart. 1986. Altered sites of tyrosine phosphorylation in pp60c-src associated with polyoma middle tumor antigen. Mol. Cell. Biol. 6:1562–1570.
   PubMedGoogle Scholar
• Cheng, S. H., H. Piwnica-Worms, R. W. Harvey, T. M. Roberts, and A. E. Smith. 1988. The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus. Mol. Cell. Biol. 8:1736–1747.
   PubMedGoogle Scholar
• Chinkers, M., and J. S. Brugge. 1984. Characterization of structural domains of the human epidermal growth factor receptor obtained by partial proteolysis. J. Biol. Chem. 259:11534–11542.
   PubMedGoogle Scholar
• Cleveland, D. W., S. G. Fischer, M. W. Kirschner, and U. K. Laemmli. 1977. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J. Biol. Chem. 252:1102–1106.
   PubMed Web of Science ®Google Scholar
• Collett, M. S., E. Erikson, and R. L. Erikson. 1979. Structural analysis of the avian sarcoma virus transforming protein: sites of phosphorylation. J. Virol. 29:770–781.
   PubMed Web of Science ®Google Scholar
• Cooper, J. A.. 1989. The src-family of protein-tyrosine kinases. In B. Kemp, and P. F. Alewood (ed.), Peptides and protein phosphorylation. CRC Press, Inc., Boca Raton, Fla.
   Google Scholar
• Cooper, J. A., K. L. Gould, C. A. Cartwright, and T. Hunter. 1986. Tyr527 is phosphorylated in p60c-src: implications for regulation. Science 231:1431–1434.
   PubMed Web of Science ®Google Scholar
• Cooper, J. A., and C. S. King. 1986. Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src. Mol. Cell. Biol. 6:4467–4477.
   PubMedGoogle Scholar
• Cooper, J. A., and A. MacAuley. 1988. Potential positive and negative autoregulation of p60c-src by intermolecular autophosphorylation. Proc. Natl. Acad. Sci. USA 85:4232–4236.
   PubMed Web of Science ®Google Scholar
• Cooper, J. A., and K. Runge. 1987. Avian pp60c-src is more active when expressed in yeast than in vertebrate fibroblasts. Oncogene Res. 1:297–310.
   PubMedGoogle Scholar
• Courtneidge, S. A.. 1985. Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation. EMBO J. 4:1471–1477.
   PubMedGoogle Scholar
• Ellis, L., E. Clauser, D. O. Morgan, M. Edery, R. A. Roth, and W. J. Rutter. 1986. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45:721–732.
   PubMed Web of Science ®Google Scholar
• Hunter, T., and J. A. Cooper. 1986. Viral oncogenes and tyrosine phosphorylation, p. 191–246. In P. D. Boyer, and E. G. Krebs (ed.), The enzymes, vol. 17. Academic Press, Inc., Orlando, Fla.
   Google Scholar
• Jove, R., S. Kornbluth, and H. Hanafusa. 1987. Enzymatically inactive p60c-src mutant with altered ATP-binding site is fully phosphorylated in its carboxy-terminal regulatory region. Cell 50:937–943.
   PubMedGoogle Scholar
• Jove, R., B. J. Mayer, H. Iba, D. Laugier, F. Poirier, G. Calothy, T. Hanafusa, and H. Hanafusa. 1986. Genetic analysis of p60v-src domains involved in the induction of different cell transformation parameters. J. Virol. 60:840–848.
   PubMedGoogle Scholar
• Kato, J., T. Takeya, C. Grandori, H. Iba, J. B. Levy, and H. Hanafusa. 1986. Amino acid substitutions sufficient to convert the nontransforming p60c-src protein to a transforming protein. Mol. Cell. Biol. 6:4155–4160.
   PubMed Web of Science ®Google Scholar
• Kitamura, N., and M. Yoshida. 1983. Small deletion in src of Rous sarcoma virus modifying transformation phenotypes: identification of 207-nucleotide deletion and its smaller product with protein kinase activity. J. Virol. 46:985–992.
   PubMedGoogle Scholar
• Kmiecik, T. E., P. J. Johnson, and D. Shalloway. 1988. Regulation by the autophosphorylation site in overexpressed pp60c-src. Mol. Cell. Biol. 8:4541–4546.
   PubMed Web of Science ®Google Scholar
• Kmiecik, T. E., and D. Shalloway. 1987. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49:65–73.
   PubMed Web of Science ®Google Scholar
• Laudano, A. P., and J. M. Buchanan. 1986. Phosphorylation of tyrosine in the carboxyl-terminal tryptic peptide of pp60c-src. Proc. Natl. Acad. Sci. USA 83:892–896.
   PubMedGoogle Scholar
• Levinson, A. D., S. A. Courtneidge, and J. M. Bishop. 1981. Structural and functional domains of the Rous sarcoma virus transforming protein (pp60src). Proc. Natl. Acad. Sci. USA 78:1624–1628.
   PubMed Web of Science ®Google Scholar
• Levy, J. B., H. Iba, and H. Hanafusa. 1986. Activation of the transforming potential of p60c-src by a single amino acid change. Proc. Natl. Acad. Sci. USA 83:4228–4232.
   PubMed Web of Science ®Google Scholar
• Lipsich, L. A., A. J. Lewis, and J. S. Brugge. 1983. Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma virus. J. Virol. 48:352–360.
   PubMedGoogle Scholar
• MacAuley, A., and J. A. Cooper. 1988. The carboxy-terminal sequence of p56lck can regulate p60c-src. Mol. Cell. Biol. 8:3560–3564.
   PubMedGoogle Scholar
• Patschinsky, T., T. Hunter, F. S. Esch, J. A. Cooper, and B. M. Sefton. 1982. Analysis of the sequence of amino acids surrounding sites of tyrosine phosphorylation. Proc. Natl. Acad. Sci. USA 79:973–977.
   PubMed Web of Science ®Google Scholar
• Patschinsky, T., T. Hunter, and B. M. Sefton. 1986. Phosphorylation of the transforming protein of Rous sarcoma virus: direct demonstration of the phosphorylation of serine 17 and identification of an additional site of tyrosine phosphorylation in p60v-src of Prague Rous sarcoma virus. J. Virol. 59:73–81.
   PubMedGoogle Scholar
• Piwnica-Worms, H., K. B. Saunders, T. M. Roberts, A. E. Smith, and S. H. Cheng. 1987. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell 49:75–82.
   PubMed Web of Science ®Google Scholar
• Potts, W. M., A. B. Reynolds, T. J. Lansing, and J. T. Parsons. 1988. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95. Oncogene Res. 3:343–355.
   PubMedGoogle Scholar
• Prywes, R., J. G. Foulkes, and D. Baltimore. 1985. The minimum transforming region of v-abl is the segment encoding proteintyrosine kinase. J. Virol. 54:114–122.
   PubMed Web of Science ®Google Scholar
• Raibaud, O., and M. E. Goldberg. 1973. Characterization of two complementary polypeptide chains obtained by proteolysis of rabbit muscle phosphorylase. Biochemistry 12:5154–5161.
   PubMedGoogle Scholar
• Raymond, V. W., and J. T. Parsons. 1987. Identification of an amino terminal domain required for the transforming activity of the Rous sarcoma virus src protein. Virology 160:400–410.
   PubMedGoogle Scholar
• Reynolds, A. B., J. Vila, T. J. Lansing, W. M. Potts, M. J. Weber, and J. T. Parsons. 1987. Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy-terminus. EMBO J. 6:2359–2364.
   PubMed Web of Science ®Google Scholar
• Rosen, O. M., R. Herrera, Y. Olowe, L. M. Petruzzelli, and M. H. Cobb. 1983. Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc. Natl. Acad. Sci. USA 80:3237–3240.
   PubMed Web of Science ®Google Scholar
• Roth, C. W., N. D. Richert, I. Pastan, and M. M. Gottesman. 1983. Cyclic AMP treatment of Rous sarcoma virus-transformed Chinese hamster ovary cells increases phosphorylation of pp60src and increases pp60src kinase activity. J. Biol. Chem. 258:10768–10773.
   PubMedGoogle Scholar
• Sadowski, I., J. C. Stone, and T. Pawson. 1986. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fuji- nami sarcoma virus P130gag-fps Mol. Cell. Biol. 6:4396–4408.
   Google Scholar
• Schuh, S. M., and J. S. Brugge. 1988. Investigation of factors that influence phosphorylation of pp60c-src on tyrosine 527. Mol. Cell. Biol. 8:2465–2471.
   PubMed Web of Science ®Google Scholar
• Smart, J. E., H. Opperman, A. P. Gernilofsky, A. F. Purchiv, R. L. Erikson, and J. M. Bishop. 1981. Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src). Proc. Natl. Acad. Sci. USA 78:6013–6017.
   PubMed Web of Science ®Google Scholar
• Snyder, M. A., and J. M. Bishop. 1984. A mutation at the major phosphotyrosine in pp60v-src alters oncogenic potential. Virology 136:375–386.
   PubMedGoogle Scholar
• Sprang, S., and R. J. Fletterick. 1979. The structure of glycogen phosphorylase a at 2.5A resolution. J. Mol. Biol. 131:523–551.
   PubMed Web of Science ®Google Scholar
• Sprang, S. R., K. R. Acharya, E. J. Goldsmith, D. I. Stuart, K. Varvill, R. J. Fletterick, N. B. Madsen, and L. N. Johnson. 1988. Structural changes in glycogen phosphorylase induced by phosphorylation. Nature (London) 336:215–221.
   PubMedGoogle Scholar
• Stoker, A. W., S. Kellie, and J. A. Wyke. 1986. Intracellular localization and processing of pp60v-src proteins expressed by two distinct temperature-sensitive mutants of Rous sarcoma virus. J. Virol. 58:876–883.
   PubMedGoogle Scholar
• Tornquist, H. E., M. W. Pierce, A. R. Frackelton, R. A. Nemenoff, and J. Avruch. 1987. Identification of insulin receptor tyrosine residues autophosphorylated in vitro. J. Biol. Chem. 262:10212–10219.
   PubMedGoogle Scholar
• Weber, I. T., L. N. Johnson, K. S. Wilson, D. G. R. Yeates, D. L. Wild, and J. A. Jenkins. 1978. Crystallographic studies on the activity of glycogen phosphorylase b. Nature (London) 274:433–437.
   PubMed Web of Science ®Google Scholar
• Weinmaster, G., M. J. Zoller, M. Smith, E. Hinze, and T. Pawson. 1984. Mutagenesis of Fujinami sarcoma virus: evidence that tyrosine phosphorylation of p130gag-fps modulates its biological activity. Cell 37:559–568.
   PubMedGoogle Scholar
• Wilkerson, V. W., D. L. Bryant, and J. T. Parsons. 1985. Rous sarcoma virus variants that encode src proteins with an altered carboxy terminus are defective for cellular transformation. J. Virol. 55:314–321.
   PubMedGoogle Scholar
• Yaciuk, P., M. T. Cannella, and D. Shalloway. 1988. Comparison of the effects of carboxyl terminal truncation and point mutations on pp60c-src activities. Oncogene Res. 3:207–212.
   PubMedGoogle Scholar
• Yaciuk, P., and D. Shalloway. 1986. Features of the pp60v-src carboxyl terminus that are required for transformation. Mol. Cell. Biol. 6:2807–2819.
   PubMedGoogle Scholar